Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marketing In Brief

Executive Summary

Neutrogena: Visibly Firm skin care extended with Face Lotion SPF 20 and Body Lotion, which contain brand's Active Copper technology, Johnson & Johnson division says. Formulated with broad spectrum UVA/UVB sunscreen protection, Face Lotion "helps restore skin's firmness" and elasticity for noticeable results after one week of daily use, Neutrogena claims. Applied twice a day, Body Lotion provides "more toned, resilient" skin with improved texture in two weeks, firm says. Bowing now, 1.7 oz. face and 8.5 oz. body items retail for $19 and $9.99, respectively. Visibly Firm debuted last year and comprises six items including eye treatment products and makeup (1"The Rose Sheet" Feb. 26, 2001, p. 4)...
Advertisement

Related Content

Neutrogena Visibly Firm Takes Elemental Approach With Active Copper
Neutrogena Visibly Firm Takes Elemental Approach With Active Copper
Salon Selectives Fashion-Inspired Hair Care Revamp Set For September
Advertisement
UsernamePublicRestriction

Register

RS010205

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel